AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Pretax margin (%)

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥106B
P/E ratio
19.6x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202510.2+83.98%
Mar 31, 20245.5+7.36%
Mar 31, 20235.1-2.51%
Mar 31, 20225.3-15.77%
Mar 31, 20216.3-15.71%
Mar 31, 20207.4-10.52%
Mar 31, 20198.3-1.65%
Mar 31, 20188.4-10.38%
Mar 31, 20179.4-43.68%
Mar 31, 201616.7+22.21%
Mar 31, 201513.7-16.56%
Mar 31, 201416.4-5.95%
Mar 31, 201317.4+17.93%
Mar 31, 201214.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)